Furthermore, we detected a significant upregulation of UHMK1 expression in advanced breast cancer, cervical squamous cell carcinoma and endocervical adenocarcinoma, lymphoid neoplasm, diffuse large B-cell lymphoma, esophageal carcinoma, skin cutaneous melanoma, stomach adenocarcinoma, and thymoma. This evidence concerns the gene UHMK1 and diffuse large B-cell lymphoma.